{"Name":"Ultragenyx Pharmaceutical","perma":"ultragenyx-pharmaceutical","BasicInfo":{"funded":"2010-01-01","isClosed":false,"closed":null,"short":"Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases."},"FundingRounds":[{"funding_type":"post_ipo_equity","series":null,"announcedDate":"2016-06-07","moneyRaised":65000000},{"funding_type":"private_equity","series":null,"announcedDate":"2012-12-31","moneyRaised":75000005},{"funding_type":"venture","series":"a","announcedDate":"2012-07-30","moneyRaised":15100000},{"funding_type":"venture","series":"a","announcedDate":"2011-06-20","moneyRaised":45000000}],"Acquisitions":[],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"RARE","shares":5700000,"date":"2014-01-31","openPrice":21,"moneyRaised":121000000,"valuation":436000000},"Investments":[],"Products":[],"CurrentTeam":[{"title":"Chief Business Officer and Senior Vice President","started":null,"ended":null,"firstName":"Thomas","lastName":"Kassberg"},{"title":"Director","started":"2011-05-01","ended":null,"firstName":"Ben","lastName":"Auspitz"},{"title":"SVP Finance & CFO","started":null,"ended":null,"firstName":"Shalini","lastName":"Sharp"},{"title":"Founder , President & CEO","started":null,"ended":null,"firstName":"Emil","lastName":"D. Kakkis"}],"PastTeam":[]}
